Objectives: The pathogenetic mechanisms that regulate the aggressive behavior of pancreatic cancer still remain to be clarified. Alterations in the apoptotic pathway and proliferative activity of tumor cells as well as mechanisms contributing to the intrinsic drug resistance of pancreatic tumors have been investigated. Survivin is a recently described antiapoptotic protein, which, when overexpressed, is associated with worse prognosis in a majority of tumors. P-glycoprotein, a product of multidrug resistance gene-1 (MDR-1) was reported to be expressed in drug-resistant tumors. The purpose of this study was to investigate whether apoptosis, its regulation by survivin, tumor cell proliferation, and P-glycoprotein expression have a significant...
WOS: 000341234800004PubMed ID: 25090821Introduction : Pancreas ductal adenocarcinoma (PDAC) is among...
Pancreatic cancer remains one of the most lethal and poorly understood human malignancies and will c...
Survivin is an inhibitor of apoptosis and its over expression is associated with poor prognosis in s...
Objectives: The pathogenetic mechanisms that regulate the aggressive behavior of pancreatic cancer s...
Pancreatic cancer is one of the most aggressive gastrointestinal cancer with less than 10% long-term...
Pancreatic cancer is estimated to be the fourth most common cancer in men and fifth in women in the ...
Background: Survival after surgery for pancreatic ductal adenocarcinoma (PDAC) remains poor. Thus, n...
Pancreatic cancer is a disease with high resistance to most common therapies and therefore has a poo...
Pancreatic cancer is a disease with high resistance to most common therapies and therefore has a poo...
Since the phenomenon was first identified, apoptosis has been proposed to serve as a barrier to the ...
202 pagesPancreatic cancer is a highly aggressive and deadly type of cancer, and effective strategie...
Treating pancreatic ductal adenocarcinoma (PDAC) remains a major hurdle in the field of oncology. Le...
The Author(s) 2011. This article is published with open access at Springerlink.com Background Better...
46 pagesA vast majority of pancreatic ductal adenocarcinomas (PDACs) have mutations in KRAS. This ty...
Background: Survivin, a novel antiapoptotic gene has been linked with tumor development and progress...
WOS: 000341234800004PubMed ID: 25090821Introduction : Pancreas ductal adenocarcinoma (PDAC) is among...
Pancreatic cancer remains one of the most lethal and poorly understood human malignancies and will c...
Survivin is an inhibitor of apoptosis and its over expression is associated with poor prognosis in s...
Objectives: The pathogenetic mechanisms that regulate the aggressive behavior of pancreatic cancer s...
Pancreatic cancer is one of the most aggressive gastrointestinal cancer with less than 10% long-term...
Pancreatic cancer is estimated to be the fourth most common cancer in men and fifth in women in the ...
Background: Survival after surgery for pancreatic ductal adenocarcinoma (PDAC) remains poor. Thus, n...
Pancreatic cancer is a disease with high resistance to most common therapies and therefore has a poo...
Pancreatic cancer is a disease with high resistance to most common therapies and therefore has a poo...
Since the phenomenon was first identified, apoptosis has been proposed to serve as a barrier to the ...
202 pagesPancreatic cancer is a highly aggressive and deadly type of cancer, and effective strategie...
Treating pancreatic ductal adenocarcinoma (PDAC) remains a major hurdle in the field of oncology. Le...
The Author(s) 2011. This article is published with open access at Springerlink.com Background Better...
46 pagesA vast majority of pancreatic ductal adenocarcinomas (PDACs) have mutations in KRAS. This ty...
Background: Survivin, a novel antiapoptotic gene has been linked with tumor development and progress...
WOS: 000341234800004PubMed ID: 25090821Introduction : Pancreas ductal adenocarcinoma (PDAC) is among...
Pancreatic cancer remains one of the most lethal and poorly understood human malignancies and will c...
Survivin is an inhibitor of apoptosis and its over expression is associated with poor prognosis in s...